|
1
|
Arch Venture Management
Chicago,
Illinois
|
$30.5M
|
–
|
–
|
–
|
|
|
2
|
Cormorant Asset Management
Boston,
Massachusetts
|
$29.8M
|
–
|
–
|
–
|
|
|
3
|
Armistice Capital
New York
|
$21.7M
|
+$1.44M
|
+506,000
|
+7%
|
|
|
4
|
|
$19.1M
|
+$4.4M
|
+1,545,305
|
+29%
|
|
|
5
|
Vanguard Group
Malvern,
Pennsylvania
|
$18.3M
|
+$1.65M
|
+579,443
|
+10%
|
|
|
6
|
PFM Health Sciences
San Francisco,
California
|
$13.2M
|
–
|
–
|
–
|
|
|
7
|
|
$13M
|
–
|
–
|
–
|
|
|
8
|
Geode Capital Management
Boston,
Massachusetts
|
$4.46M
|
+$260K
|
+91,167
|
+6%
|
|
|
9
|
Prosight Management
Dallas,
Texas
|
$4.3M
|
+$1.08M
|
+378,280
|
+32%
|
|
|
10
|
State Street
Boston,
Massachusetts
|
$4.11M
|
+$629K
|
+220,712
|
+17%
|
|
|
11
|
International Biotechnology Trust
London,
United Kingdom
|
$3.92M
|
–
|
–
|
–
|
|
|
12
|
Citadel Advisors
Miami,
Florida
|
$3.58M
|
-$5.79M
|
-2,033,736
|
-61%
|
|
|
13
|
Millennium Management
New York
|
$3.29M
|
-$1.21M
|
-423,976
|
-26%
|
|
|
14
|
Nuveen
Charlotte,
North Carolina
|
$3.26M
|
+$1.33M
|
+468,305
|
+66%
|
|
|
15
|
Renaissance Technologies
New York
|
$3.18M
|
-$872K
|
-305,990
|
-21%
|
|
|
16
|
|
$2.83M
|
+$1.6M
|
+560,260
|
+121%
|
|
|
17
|
|
$2.45M
|
–
|
–
|
–
|
|
|
18
|
Two Sigma Investments
New York
|
$2.01M
|
-$152K
|
-53,447
|
-7%
|
|
|
19
|
Northern Trust
Chicago,
Illinois
|
$1.92M
|
+$110K
|
+38,472
|
+6%
|
|
|
20
|
Two Sigma Advisers
New York
|
$1.78M
|
+$607K
|
+213,200
|
+50%
|
|
|
21
|
|
$1.74M
|
-$282K
|
-98,897
|
-14%
|
|
|
22
|
Bank of America
Charlotte,
North Carolina
|
$1.71M
|
-$6.71M
|
-2,356,385
|
-79%
|
|
|
23
|
Charles Schwab
San Francisco,
California
|
$1.6M
|
+$90K
|
+31,610
|
+6%
|
|
|
24
|
AH Equity Partners LSV II
Menlo Park,
California
|
$863K
|
–
|
–
|
–
|
|
|
25
|
Algert Global
San Francisco,
California
|
$808K
|
+$620K
|
+217,500
|
+289%
|
|
